Skip to content

Skeletal Muscle Energetics and Fatiguability in Older Individuals

Skeletal Muscle Energetics and Fatiguability in Older Individuals

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04142047
Enrollment
200
Registered
2019-10-29
Start date
2019-09-05
Completion date
2027-07-01
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV, HIV Infections

Brief summary

The investigators are studying whether metabolic abnormalities in calf (leg) muscle in older people with and others without HIV are associated with decreased abilities to exercise.

Detailed description

This research is being done to better understand why some older people living with HIV experience more fatigue and difficulty exercising than older people without HIV. This is important because fatigue and problems exercising are predictors of disability and hospitalization in older individuals. We will use non-invasive magnetic resonance imaging (MRI) and spectroscopy (MRS) of the leg muscle to measure muscle metabolites and fat content, as well as blood samples measures levels of inflammation.

Interventions

None listed

Sponsors

Johns Hopkins University
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants who are \>= 60 years of age * HIV serostatus positive participants on stable antiretroviral therapy (ART) (no regimen change in last month) with undetectable HIV viral load (\<100 copies). * HIV serostatus negative participants

Exclusion criteria

* Unable to understand the risks, benefits, and alternatives of participation and give meaningful consent * Contraindications to MRI * Significant cardiovascular, pulmonary or musculoskeletal or orthopedic disease that significantly limits exercise capacity * Significant lower extremity peripheral vascular disease. * Weight greater than 350 lbs * Cognitive or speech impairments that would limit completion of questionnaires or fatigue reporting.

Design outcomes

Primary

MeasureTime frameDescription
Maximal mitochondrial oxidative capacity (VmaxPCr)BaselineMaximal oxidative capacity of leg muscle measured by 31P Magnetic Resonance Spectroscopy (MRS)
Rate of PCr decline during plantar flexion exerciseBaseline
Six minute walk distanceBaseline

Secondary

MeasureTime frameDescription
Skeletal muscle fat contentBaseline
Gait speedBaseline
Frailty status (as measured by the Fried Frailty Index)BaselineFried frailty index described in J Gerontol A bill Sci-Fi Med Sci-Fi 2001;56:M146-56

Countries

United States

Contacts

CONTACTMaria Esteban, RN, BSN
mesteba1@jh.edu410-955-1160
CONTACTTricia Steinberg, RN, MSN
asteinb3@jhmi.edu443-287-3469
PRINCIPAL_INVESTIGATORRobert G Weiss, MD

Johns Hopkins University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026